Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanomaMichele Maio, Paolo A. Ascierto, Lorenza Di Guardo et al.|Annals of Oncology|2013Cited by 141
Sequential Treatment with Ipilimumab and BRAF Inhibitors in Patients With Metastatic Melanoma: Data From the Italian Cohort of the Ipilimumab Expanded Access ProgramPaolo A. Ascierto, Michele Maio, Ester Simeone et al.|Cancer Investigation|2014Cited by 105
Correlation between efficacy and toxicity in pts with pretreated advanced melanoma treated within the Italian cohort of the ipilimumab expanded access programme (EAP).Anna Maria Di Giacomo, Vanna Chiarion‐Sileni, Antonio Maria Grimaldi et al.|Journal of Clinical Oncology|2013Cited by 15
Tebentafusp in metastatic uveal melanoma patients: Results of the Italian expanded access program.Ernesto Rossi, Paolo A. Ascierto, Lorenza Di Guardo et al.|Journal of Clinical Oncology|2025Cited by 2